Key Data:
Order announcement
23 May 2002
Location
Clondalkin, South Dublin, Ireland
Estimated investment
€90m ($105m)
Completion
Final quarter of 2004
Output chemicals
Pioglitazone hydrochloride (Actos) and other drugs for clinical trials
Key Players:
Sponsors
Takeda Chemical Industries Ltd, Takeda Pharma Ireland Ltd (TPI), IDA Ireland, South Dublin County Council
Lead engineer / designer
Foster Wheeler Energy, Ishikawajima-Harima Heavy Industries Co., Ltd (IHI)
Validation
Foster Wheeler Energy
Project management
Project Management Group
Financing
Takeda Chemical Industries Ltd